354 results on '"Nijman, Hans W."'
Search Results
2. Diagnostic accuracy of MRI, CT, and [18F]FDG-PET-CT in detecting lymph node metastases in clinically early-stage cervical cancer — a nationwide Dutch cohort study
3. ImmunoPET provides a novel way to visualize the CD103+ tissue-resident memory T cell to predict the response of immune checkpoint inhibitors
4. Automated causal inference in application to randomized controlled clinical trials
5. Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET
6. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
7. Tumour-infiltrating lymphocytes: from prognosis to treatment selection
8. Prognostic benefit of TILs independent of clinicopathological and molecular factors
9. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts
10. p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial
11. Prediction of recurrence risk in endometrial cancer with multimodal deep learning
12. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
13. Diagnostic accuracy of MRI, CT, and [18F]FDG-PET-CT in detecting lymph node metastases in clinically early-stage cervical cancer: a nationwide Dutch cohort study
14. Tumor-infiltrating lymphocytes in the immunotherapy era
15. Borderline ovarian tumor frozen section diagnoses with features suspicious of invasive cancer: a retrospective study
16. Borderline tumours of the ovary: Common practice in the Netherlands
17. Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative
18. Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies
19. ImmunoPET provides a novel way to visualize the CD103+ tissue-resident memory T cell to predict the response of immune checkpoint inhibitors.
20. Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET.
21. End-of-life care for patients with advanced ovarian cancer in the Netherlands
22. Abstract 5695: Deep learning risk prediction model of distant recurrence from H&E endometrial cancer slides
23. Stage, treatment and survival of low‐grade serous ovarian carcinoma in the Netherlands: A nationwide study
24. Spontaneous Human Squamous Cell Carcinomas are Killed by a Human Cytotoxic T Lymphocyte Clone Recognizing a Wild-Type p53-Derived Peptide
25. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts
26. A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases
27. Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer
28. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
29. Tumour-infiltrating lymphocytes: from prognosis to treatment selection
30. Homologous Recombination Deficiency and Cyclin E1 Amplification Are Correlated with Immune Cell Infiltration and Survival in High-Grade Serous Ovarian Cancer
31. Development of89Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration
32. Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate with improved survival
33. Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study
34. Treatment of bulky lymph nodes in locally advanced cervical cancer: boosting versus debulking
35. Automated causal inference in application to randomized controlled clinical trials
36. Treatment of bulky lymph nodes in locally advanced cervical cancer:boosting versus debulking
37. Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial:Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
38. Primary or adjuvant chemoradiotherapy for cervical cancer with intraoperative lymph node metastasis – A review
39. Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
40. Automated causal inference in application to randomized controlled clinical trials
41. Treatment of bulky lymph nodes in locally advanced cervical cancer: boosting versus debulking
42. Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer
43. Until Which Age Should Women Be Vaccinated Against HPV Infection? Recommendation Based on Cost-effectiveness Analyses
44. Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component
45. Tumor infiltrating CD8/CD103/ TIM-3-expressing lymphocytes in epithelial ovarian cancer coexpress CXCL13 and associate with improved survival.
46. Strategies to Target Tumor Immunosuppression
47. Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial
48. Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer:Implications for shared decision making
49. Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making
50. Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.